An audit of fusion CT-PET in the management of colorectal liver metastases.

摘要: Abstract Aim To assess the use of positron emission tomography combined with computerized (CT-PET) fluoro-18-2-deoxy- d -glucose ( 18 F-FDG) to identify hyper-metabolic tumours, especially colorectal metastases (CRM). Methods Patient particulars, diagnoses and clinical outcome for each patient were studied. Twenty-three patients underwent CT-PET, 10 males 13 females, median age 59 (range 34–72). Fourteen presented primary liver CRM nine had undergone previous resections. Indications CT-PET included; suspected extrahepatic disease in 13/23 patients, possible hepatic recurrence 5/23 suspicion 8/23 patients. Results Seven a major impact on their management. Unexpected (not seen CT) findings group included, 7/23 (30%) disease, 3/23 metastases, having or distant CT negative study. A decision, based report, could be undertaken 21/23 Conclusion is useful where conventional imaging presents dilemmas such as: assessment liver, advanced perforated initial tumours.